These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4768173)

  • 41. [The current achievements and problems of thrombolytic therapy].
    Bokarev IN
    Ter Arkh; 1992; 64(10):101-5. PubMed ID: 1485236
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experiences with prolonged anticoagulant therapy at our outpatient clinic].
    Adler M; Gortvai G; Adamovits Z
    Orv Hetil; 1969 Sep; 110(39):2287-9. PubMed ID: 5350579
    [No Abstract]   [Full Text] [Related]  

  • 43. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anticoagulants in coronary disease].
    Popescu P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):329-34. PubMed ID: 14368
    [No Abstract]   [Full Text] [Related]  

  • 45. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical aspects of thrombolytic therapy].
    Schmutzler R
    Internist (Berl); 1969 Jan; 10(1):21-9. PubMed ID: 4906437
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibrinolytic drugs in acute myocardial infarction.
    Drug Ther Bull; 1988 Jun; 26(12):45-8. PubMed ID: 3292184
    [No Abstract]   [Full Text] [Related]  

  • 48. [Current principles of treating acute thromboses and embolisms of the magistral arteries in the extremities].
    Mirza-Avakian GL
    Zh Eksp Klin Med; 1970 Jun; 10(6):53-9. PubMed ID: 5520568
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
    Harenberg J; Heene DL
    Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angiocyclan in the treatment of vascular diseases. Controlled clinical results].
    Bracale GC; Renda A
    Minerva Cardioangiol; 1975 Mar; 23(3):170-6. PubMed ID: 1128768
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapy of coronary arteriosclerosis and its complications].
    Giordano MP; Allegri M
    Clin Ter; 1972 Feb; 60(3):259-74. PubMed ID: 4665993
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fibrinolytic treatment of acute myocardial infarction].
    Hoechst N
    Tidsskr Nor Laegeforen; 1990 Jan; 110(2):248. PubMed ID: 2300965
    [No Abstract]   [Full Text] [Related]  

  • 53. [For and against fibrinolytic treatment of myocardial infarction].
    Sterkowicz S
    Wiad Lek; 1968 Dec; 21(24):2243-7. PubMed ID: 5707600
    [No Abstract]   [Full Text] [Related]  

  • 54. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Indications and possibilities of conservative therapy in the treatment of acute arterial occlusions of the extremities].
    Pollazzon G; Salvadego L; Cinti C
    Acta Anaesthesiol; 1968; 19(6):1181-99. PubMed ID: 5756943
    [No Abstract]   [Full Text] [Related]  

  • 56. Protracted use of dicoumarol anticoagulants in the treatment of peripheral arteriopathies.
    Raso AM; Roviera C; Scevola G
    Panminerva Med; 1975; 16(7-8):238-45. PubMed ID: 45868
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2008 Dec; 28(5):428-37. PubMed ID: 19132172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Are there indications for the administration of thrombolytic agents?].
    Bieger R; Loeliger EA
    Ned Tijdschr Geneeskd; 1972 Nov; 116(45):2042-6. PubMed ID: 4639588
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulant therapy: a critique.
    Gross H; Hasson J; Solomon S
    Am Fam Physician; 1971 Jun; 3(6):87-91. PubMed ID: 5580625
    [No Abstract]   [Full Text] [Related]  

  • 60. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.